Creative Medical Technology Holdings Inc
CELZ
NASDAQ
Biotechnology
$1.22
USD
-0.02 (-1.61%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $8.17M
Volume 665.3K
About Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The company is headquartered in Phoenix, Arizona and currently employs 4 full-time employees. The company went IPO on 2009-05-01. The firm conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
CEO
Mr. Timothy Warbington
HQ
Phoenix, ARIZONA, US
Founded
2009
Employees
4
Quantli Score
8.4
Outperform
Fin. Health
8.1
Profitability
7.6
Growth
9.0
Cash-Flow Q.
8.8
Key Metrics
6 metrics our research team weighs before forming a view on CELZ.
Based on Quantli research · SEC filings · as of Q1 2026
METRIC
VALUE
CHANGE
TREND (3Y)
Revenue Growth (TTM)
-78.6%
-134.1 pp
Gross Margin (TTM)
66.9%
+6.9 pp
Operating Margin (TTM)
-198049.6%
-153184.0 pp
Net Margin (TTM)
-192066.3%
-148566.0 pp
ROE (TTM)
-94.0%
-18.4 pp
Free Cash Flow (TTM)
$-5.59M
—
Financial Snapshot
Revenue
$3,000
-78.6%
YoY
Gross Margin
67%
TTM
+11.4%
YoY
Net Income
$-5.76M
+5.4%
YoY
Operating Cash Flow
$-5.59M
+6.8%
YoY
Key Statistics
Open
$1.22
Previous Close
$1.24
Day Range
$1.19 - $1.28
52 Week Range
$0.62 - $6.25
Volume
665.3K
Average Volume (10 Days)
38.9M
Dividend Yield
—
Valuation Measurement
Market Cap
$8.17M
P/E Ratio (TTM)
—
P/S Ratio (TTM)
2723.33
Price / Book
1.33
Financial Highlights
Profit Margin
-192066.3%
Return on Assets
-89.5%
Return on Equity
-94.0%
Revenue (TTM)
$3,000
Net Income (TTM)
$-5.76M
Diluted EPS (TTM)
-$2.13
Total Cash (MRQ)
$5.72M
Levered FCF (TTM)
$-5.59M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
